中英医疗科创高峰论坛在京举行，BMJ推动两国医疗创新与协作

Core Viewpoint - The 2025 Capital International Medical Conference's parallel forum, the China-UK Medical Technology Innovation Summit, emphasizes collaboration and development in the medical technology sector between China and the UK, aiming to enhance global public health initiatives [1][3]. Group 1: Collaboration and Innovation - Medical technology innovation is a key pillar of national innovation systems and is essential for advancing the Healthy China strategy and improving public health [3]. - The China Hospital Association and BMJ Group are fostering a collaborative environment to enhance medical technology cooperation between China and the UK, focusing on practical and extensive partnerships [3][6]. - Specific initiatives proposed include addressing major health issues, promoting interdisciplinary collaboration, and enhancing talent development through joint participation of universities, hospitals, and enterprises [4][10]. Group 2: Ecosystem and Policy Support - The UK has developed a comprehensive innovation ecosystem supported by policies that facilitate research, technology transfer, and industrial application, while China is transitioning from a "big pharmaceutical country" to a "strong pharmaceutical country" [8][9]. - Beijing is positioning itself as a core area for high-quality development in the pharmaceutical and health industry, implementing various innovative policies and programs to enhance clinical research and drug development [9][10]. Group 3: Internationalization and Market Potential - The global innovation drug market has seen significant growth, with China emerging as a key player in clinical research and drug development, evidenced by a substantial increase in licensing fees and clinical trial projects [11]. - The Chinese medical device market is projected to reach 1.3 trillion yuan in 2023, indicating a 17% year-on-year growth, although there remains a gap in the drug-to-device ratio compared to global averages [12]. Group 4: AI and Future Directions - AI technology is increasingly being integrated into medical innovation, although challenges such as data compatibility and clinical demand alignment persist [14]. - The potential for AI to enhance clinical data management and improve healthcare delivery is recognized, with recommendations for developing interdisciplinary talent in AI and healthcare [14][15]. Group 5: Sustainable Cooperation Mechanisms - Establishing sustainable cooperation mechanisms is crucial for maximizing the value of medical technology innovation globally, with emphasis on strategic alignment, research matching, and talent training [15][16]. - The UK and China are encouraged to deepen data sharing and collaborative research to address common health challenges, leveraging each country's strengths in data resources and clinical applications [17][18].